Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

ElitePhysiqMD vs ElixaMD

ElitePhysiqMD
Graded #166

Higher grade

vs+4.099999999999994
ElixaMD
Graded #258

Lower grade

The verdict

ElitePhysiqMD takes it — 67.6/100 to 63.5/100.

ElitePhysiqMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. ElitePhysiqMD is a physician-led telehealth platform prescribing compounded semaglutide (from $145/mo) and tirzepatide (from $315/mo subscription) to patients in all 50 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueElitePhysiqMD +24
74
50
Dose & formulationElitePhysiqMD +12
64
52
Clinical oversightElixaMD +13
79
92
Labs & monitoringElixaMD +11
52
63
FulfillmentElixaMD +7
69
76
Contract termsElitePhysiqMD +10
55
45
ElitePhysiqMD · left barElixaMD · right bar

The numbers

MetricElitePhysiqMDElixaMD
WeighScore67.6/10063.5/100
GradeCC
Scorecard rank#166#258
Semaglutide$145/mo (starting dose, compounded)$179/mo (starting dose, first-month rate, compounded)
Tirzepatide$315/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
ElitePhysiqMD

Graded #166 · C

Strengths

  • Compounded semaglutide from $145/mo subscription with no video calls and cancel-anytime policy
  • LegitScript certified, HIPAA-compliant; prescriptions from board-certified physicians via 5-min online assessment
  • Medications from US-licensed 503A/503B compounding pharmacies, shipped discreetly in 5–7 business days
  • HSA/FSA eligible; accepts all 50 states with no insurance required
  • Peptide therapy also available: NAD+, sermorelin, CJC-1295/ipamorelin, GHK-Cu, and glutathione

Where it loses points

  • Required $49 telehealth visit is added to every order, increasing effective monthly cost above the headline price
  • No labs disclosed; medication plans don't appear to include bloodwork or baseline testing
  • No dietitian, coaching, or nutrition support mentioned; program is medication-only
  • Tirzepatide subscription price ($315/mo) is above the mid-range for compounded tirzepatide
  • Newer platform (founded late 2025); no Trustpilot rating or public patient reviews found
ElixaMD

Graded #258 · C

Strengths

  • Compounded semaglutide from $179 first month with free shipping, no membership, no contract, and no insurance required
  • Genuinely all-inclusive: 1:1 physician guidance, free dietician visits and care coaching, 24/7 support, and an all-in-one patient portal
  • Names its compounding pharmacies (RedRock Pharmacy, Beaker Pharmacy) — more transparent than most compounded sellers
  • HSA/FSA eligible; full legal suite (Terms, Privacy, Privacy Practices, Refund, Medical Consent, California Bill of Rights)

Where it loses points

  • $179 is a first-month/intro price — ongoing monthly cost is higher (tiers to ~$249-$299)
  • Compounded semaglutide is not FDA-approved (the site discloses this) — not brand Wegovy or Ozempic
  • Appears to offer compounded semaglutide only — tirzepatide is not advertised
  • Displays a generic LegitScript Certified badge but no verifiable seal/listing; state-availability list not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard